The World Health Organization has identified cervical cancer as the number one killer of women worldwide, killing over 100,000 women each year.
And that’s just in developed countries, with a significant number of women dying in developing countries.
It’s no surprise that cervical cancer is such a serious disease in developed nations, as the global burden of cervical cancers is increasing rapidly.
Cervical cancer has been identified as a leading cause of death in many countries, but it’s only been recently that the incidence of cervical and ovarian cancer have become so common in many of the world’s most populous countries.
In developed nations like the United States, more than 90% of women will be diagnosed with a cervical or ovarian cancer within the first six months of life, according to the World Health Organisation.
The global average for cervical cancer incidence is 6.1 per 1,000 people.
In the United Kingdom, the rate of cervical or ovary cancer is currently 8.2 per 1 for men and 4.9 per 1.5 for women, according the latest data from the National Cancer Statistics Authority.
But the figures are only the beginning.
There are still millions of women in the United Arab Emirates who have had their cervix removed due to cancer or for other reasons, and they continue to die.
“What you have is an epidemic of cervical disease,” says Dr. Sarah O. Leach, chief of obstetrics at the University of New South Wales and the author of the book, “Cervix, Cancer and Health.”
Leach is currently leading a study of women from South Africa to see if cervical cancer rates are linked to the type of birth control they use.
When you look at the fact that cervical cancers are more common in the developing world, there is a reason why we’re seeing such a dramatic increase in cervical cancer in developed world nations, says Leach.
What we’re talking about is the death of the fetus in the womb, which is something we have seen for the last several hundred years, and this is because of the loss of the ability of the uterus to give birth.
This is a problem for many reasons, but what we’re looking at is the potential to do something that will have an impact on women’s overall health.
One of the things we know about is that there are chemicals that are released during the first few weeks of pregnancy, and these chemicals are also found in cervical mucus, and that’s why they’re linked to cervical cancer.
So the problem is that the drugs that are currently being developed for treating cervical cancer are not effective, because of their inability to prevent these chemical releases in the first couple of weeks of the pregnancy.
So the next time you see a woman, or a man, in a clinic, or even if you’re driving through town, you might see a lot of women with abnormal vaginal discharge, and it’s a sign of a cervical cancer, says O.R.S.C. Director of Global Health, Dr. Karen Daley.
We want to see what we can do to make the drugs available to women that we know can help protect their health, because women’s cancers are a global issue.
What we’re really focusing on is understanding why women’s cervical cancer levels are increasing so dramatically.
You have to understand the factors that are contributing to this increase in the incidence, says Daley, who has studied the incidence and prevalence of cervical carcinoma for the past 25 years.
One of the most obvious is that many women in developing nations are not using contraception, and because they are not properly trained, it can have a devastating effect on women.
Another factor is that these drugs don’t have as good of a shelf life as they used to, and so the drugs used to treat cervical cancer become less effective and more costly.
We have to think about what we could do to change that.
So we need to think beyond the fact we can’t prevent these chemicals from entering the body, Daley says.
We need to understand why women are dying and what we need in order to prevent the problem from getting worse.
There is a huge difference between a woman’s cervical health and that of a man.
In the United Nations Population Fund’s 2011 report on cervical cancer and contraception, the report said, “In developed countries with good cervical health, cervical cancer will be less likely to develop in the future, because a high proportion of women who will be in the general population in the next 20 years will have undergone the surgical procedure and given birth.”
This year, O.
C., along with other health organizations, will be gathering data on cervical health in countries around the world.
This is one of the largest studies to date.
This will be the first time that O.rs.
C is gathering data in developed and developing countries together, and the data will be used